• Self-Care for Oncology Patients
  • FDA Approves Revised Indication for Diabetic Macular Edema Treatment
  • Psoriasis and Psoriatic Arthritis Patient Care: What Pharmacists Should Know
  • OTC Product News (September 2014)
  • MTM Services Underused in Part D Drug Plans

Breaking News

New Technologies Harness Genetics in Superbug Fight
Researchers are relying on genetics to develop new approaches for combating drug-resistant bacteria.
As the Ebola outbreak worsens, interest in therapies using recovered victims’ blood grows.
A multidisciplinary group of medical and nutrition experts hopes to shed light on misconceptions about vitamin and mineral supplementation.
Pharmacist-led drug use evaluation programs improve osteoporosis management in general practice.
The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.
Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.
The current Ebola epidemic is causing the health care system in West Africa to collapse.

From the Issue

$AD300x250BB$
Previous TabNext Tab
Strategic Alliance Partners
Latest Issues
$auto_registration$